BNP Paribas Financial Markets
RCEL icon

BNP Paribas Financial Markets’s Avita Medical RCEL Stock Holding History

BNP Paribas Financial Markets’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$223K Buy
53,958
+50,791
+1,604% +$219K ﹤0.01% 4179
2026
Q1 		$11.7K Buy
3,167
+489
+18% +$2.05K ﹤0.01% 5190
2025
Q4 		$9.24K Sell
2,678
-210
-7% -$838 ﹤0.01% 5175
2025
Q3 		$14.8K Buy
2,888
+266
+10% +$1.39K ﹤0.01% 4956
2025
Q2 		$13.9K Sell
2,622
-5,930
-69% -$43.1K ﹤0.01% 4751
2025
Q1 		$69.6K Buy
8,552
+5,596
+189% +$52.3K ﹤0.01% 4173
2024
Q4 		$37.8K Buy
+2,956
New +$34.9K ﹤0.01% 4538

Other funds holding RCEL

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

BNP Paribas Financial Markets's RCEL Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Avita Medical (RCEL) stake by 1,604% in Q2 2026, buying an estimated $219K and bringing the position to 53,958 shares worth $223K. The position accounts for ﹤0.01% of the portfolio, ranked #4179.

BNP Paribas Financial Markets first reported a position in RCEL in Q4 2024 and has held it in 7 quarters since. 67 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • BNP Paribas Financial Markets held 53,958 shares of Avita Medical worth $223K as of Q2 2026.
  • BNP Paribas Financial Markets bought 50,791 Avita Medical shares in Q2 2026, an estimated $219K.
  • Avita Medical made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4179 holding.
  • BNP Paribas Financial Markets first reported a position in Avita Medical in Q4 2024 and has held it in 7 quarters since.
  • 67 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.